Marijuana startup MassRoots' plans to join Nasdaq go up in smoke

Marijuana startup MassRoots' plans to join Nasdaq go up in smoke
Nasdaq listing snub could set a precedent for marijuana stocks.
MAY 26, 2016
MassRoots, an online social network for marijuana fans, experienced a massive downer Monday when the NASDAQ exchange denied its listing request based on the fact cannabis is still illegal at the federal level. According to a statement from MassRoots, a company that is currently trading over the counter, the exchange request was denied due to concerns over aiding and abetting the distribution of an illegal substance. “With this decision, the Nasdaq has set a dangerous precedent that will prevent nearly every company in the regulated cannabis industry from listing on a national exchange,” said MassRoots chief executive Isaac Dietrich in a prepared statement. “This will have ripple effects across the entire industry, making it more difficult for cannabis entrepreneurs to raise capital and slow the progression of cannabis legalization in the United States,” he added. “This decision must not be allowed to stand and we're asking every cannabis investor, business, activist and supporter to write a brief note to the Nasdaq in support of our appeal here.” MassRoots, which applied for the listing in early April, plans to appeal the exchange's decision. MassRoots was also planning a reverse stock split if it was listed on the exchange. The stock is trading at 90 cents a share, down 42.7% from April 11 when it applied to be listed on the exchange. The stock is down 18.2% since the start of the year. The S&P 500 Index is flat from April 11, and up 1.1% since the start of the year. So far, 40 states have legalized the use of medical marijuana in some form, and four have legalized marijuana for recreational use. Even though the Department of Justice has extended for a second year through the end of 2016 a “cease fire” of federal marijuana-law enforcement over state laws, those states are still in technical violation of federal law. That is the kind of reality that has a lot of financial advisers placing pot stocks on the extreme end of the risk curve.

Latest News

Bridgewater's flagship hedge fund surges amid volatile markets
Bridgewater's flagship hedge fund surges amid volatile markets

The firm's flagship fund, which invests in stocks, bonds, currencies, and commodities, saw accelerated gains as some peers lost ground.

ICI floats '40 Act revamp to support middle-class wealth creation
ICI floats '40 Act revamp to support middle-class wealth creation

Policy proposal offers recommendations on dual-share class funds, semi-transparent ETFs, and expanded flexibility for closed-end funds to include private market assets.

Trump-induced turbulence tests 60-40 strategy's limits
Trump-induced turbulence tests 60-40 strategy's limits

With bonds failing to provide a safety net for steeply falling stock prices, many investors are letting go of their "set it and forget it" approach.

More workers dipped into their retirement savings last year, Vanguard finds
More workers dipped into their retirement savings last year, Vanguard finds

Sneak peek into annual defined contribution plan report shows average participant balances reached an all-time high amid rising equity markets.

Decades-old will leaves fate of late actor Gene Hackman's $80M fortune uncertain
Decades-old will leaves fate of late actor Gene Hackman's $80M fortune uncertain

The iconic actor's death alongside his wife, Betsy Arakawa, leaves pressing questions about what happens next to his assets.

SPONSORED Beyond the all-in-one: Why specialization is key in wealth tech

In an industry of broad solutions, firms like intelliflo prove 'you just need tools that play well together'

SPONSORED Record growth: Interval funds emerge as key players in alternative investments

Blue Vault Alts Summit highlights the role of liquidity-focused funds in reshaping advisor strategies